Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Recruiting Not applicable

Effectiveness of Functional Respiratory Muscle Training in Post-COVID-19 Syndrome

NCT07051954 · tracked via the Priya Life Science Turkey tracker
Phase
Not applicable
Started
2025-09-15
Last updated
2026-01-14

Condition(s) studied

Post COVID-19 SyndromeFunctional Inspiratory Muscle TrainingCore Stabilization

Investigational drug(s) / intervention(s)

Core StabilizationFunctional Inspiratory Muscle Training (IMT)

Core Stabilization: 12-week supervised core stabilization training, 3 sessions per week, 45 minutes per session.

Functional Inspiratory Muscle Training (IMT): IMT using a portable inspiratory muscle training device at 60% MIP, progressively increased over 12 weeks.

Study summary

This study aims to investigate the effects of core stabilization exercises and functional inspiratory muscle training (IMT) on various physiological and psychological parameters in individuals with post-COVID-19 syndrome. Participants diagnosed with post-COVID-19 syndrome will be randomly assigned to two groups using stratified computer-assisted randomization. One group will undergo an 8-week core stabilization training, while the other will receive combined core stabilization and IMT training. Exercise training will be conducted three times a week, with each session lasting 50 minutes.

Comprehensive pre- and post-intervention assessments will be conducted, including exercise capacity, respiratory and peripheral muscle strength, trunk endurance, balance, anxiety, depression, and fatigue levels. The primary outcome measures are respiratory muscle strength and trunk endurance.

Participants must be aged 18-65 years, have at least a primary education level, speak Turkish, and be classified as level 2-3 on the Post-COVID-19 Functional Status Scale (PCFS). Eligible participants will be referred by the Internal Medicine Department at Hacettepe University.

The study will utilize various assessment tools, including maximal inspiratory/expiratory pressure (MIP/MEP) tests, Functional Movement Screen (FMS), plank and Sorenson endurance tests, the Timed Up and Go Test for balance, handgrip and knee extension strength tests, body composition analysis, and the SF-36 quality of life questionnaire.

Eligibility

Sex
ALL
Min age
18 Years
Max age
65 Years
Healthy volunteers
No
Inclusion Criteria: * Diagnosed with Post-COVID-19 Syndrome. * Literate and able to understand study procedures. * Aged between 18 and 65 years. * Willing to voluntarily participate in the study. * Classified as functional class 2-3 according to the Post-COVID-19 Functional Status Scale (PCFS). * Clinically stable; comorbid conditions such as hypertension or diabetes must be controlled. * No orthopedic or neurological conditions that would prevent assessment of peripheral muscle strength, balance, or exercise capacity. Exclusion Criteria: * History of recent myocardial infarction or pulmonary embolism. * Presence of uncontrolled chronic diseases. * Any orthopedic or neurological disorders that limit mobility. * Neurological impairments (e.g., cerebrovascular disease) or psychiatric disorders that impair cooperation or compliance with exercise testing.

Primary outcome measure(s)

  • Respiratory muscle strength — Baseline and after 12 weeks of intervention.
    Maximal inspiratory pressure (MIP) and maximal expiratory pressure (MEP) with mouth-pressure device
  • Plank Endurance Test — Baseline and after 12 weeks of intervention.
    Plank Test: Plank time is a common test to evaluate core stability. The patient is given a plank position and the maximum endurance time they can hold this position is measured.
  • Sorenson Endurance Test — Baseline and after 12 weeks of intervention.
    Sorenson Test (Extensor Endurance Test): In this test, the person lies horizontally on the end of a table and is asked to keep their body in a fixed position outside the table. The endurance time in this position is evaluated to measure core stability.
  • Side Bridge Endurance Test — Baseline and after 12 weeks of intervention.
    Side Bridge Test: It is an endurance test based on time in the side plank position. The difference between the times on the right and left sides can provide information about core stabilization.

Trial sites (1)

FacilityCityRegionStatus
Hacettepe University Ankara Çankaya Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07051954 on ClinicalTrials.gov ↗ ← All trials in Turkey